Swiss National Bank Vericel Corp Transaction History

Swiss National Bank

$146 Billion
Q4 2024

A detailed history of Swiss National Bank transactions in Vericel Corp stock. As of the latest transaction made, Swiss National Bank holds 96,500 shares of VCEL stock, worth $5.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

96,500

Previous 90,400 6.75%

Holding current value

$5.02 Million

Previous $3.82 Million 38.73%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$40.05 - $59.11 $244,304 - $360,571	6,100 Added 6.75%	96,500 $5.3 Million
Q2 2024 Aug 08, 2024	BUY	$41.71 - $52.9 $37,539 - $47,610	900 Added 1.01%	90,400 $4.15 Million
Q1 2024 May 07, 2024	BUY	$32.52 - $52.33 $13,008 - $20,932	400 Added 0.45%	89,500 $4.66 Million
Q4 2023 Feb 06, 2024	SELL	$30.85 - $37.09 $314,670 - $378,318	-10,200 Reduced 10.27%	89,100 $3.17 Million
Q3 2023 Nov 08, 2023	BUY	$31.69 - $39.25 $38,028 - $47,100	1,200 Added 1.22%	99,300 $3.33 Million
Q2 2023 Aug 09, 2023	BUY	$29.0 - $38.37 $182,700 - $241,730	6,300 Added 6.86%	98,100 $3.69 Million
Q1 2023 May 10, 2023	SELL	$23.85 - $31.34 $255,195 - $335,338	-10,700 Reduced 10.44%	91,800 $2.69 Million
Q4 2022 Feb 08, 2023	BUY	$17.65 - $27.37 $33,535 - $52,003	1,900 Added 1.89%	102,500 $2.7 Million
Q3 2022 Nov 09, 2022	BUY	$22.62 - $32.54 $29,406 - $42,302	1,300 Added 1.31%	100,600 $2.33 Million
Q2 2022 Aug 09, 2022	BUY	$22.88 - $39.45 $121,264 - $209,085	5,300 Added 5.64%	99,300 $2.5 Million
Q1 2022 May 09, 2022	BUY	$31.69 - $43.29 $218,661 - $298,701	6,900 Added 7.92%	94,000 $3.59 Million
Q3 2021 Nov 08, 2021	BUY	$46.35 - $59.75 $46,350 - $59,750	1,000 Added 1.16%	87,100 $4.25 Million
Q2 2021 Aug 06, 2021	SELL	$47.2 - $67.81 $103,840 - $149,182	-2,200 Reduced 2.49%	86,100 $4.52 Million
Q1 2021 May 07, 2021	BUY	$30.93 - $59.48 $40,209 - $77,324	1,300 Added 1.49%	88,300 $4.91 Million
Q4 2020 Feb 05, 2021	SELL	$18.53 - $31.5 $87,091 - $148,050	-4,700 Reduced 5.13%	87,000 $2.69 Million
Q3 2020 Nov 09, 2020	BUY	$14.68 - $19.12 $20,552 - $26,768	1,400 Added 1.55%	91,700 $1.7 Million
Q2 2020 Aug 05, 2020	BUY	$8.5 - $15.82 $68,000 - $126,560	8,000 Added 9.72%	90,300 $1.25 Million
Q1 2020 May 08, 2020	BUY	$7.25 - $19.22 $15,225 - $40,362	2,100 Added 2.62%	82,300 $755,000
Q4 2019 Feb 06, 2020	BUY	$13.77 - $19.2 $38,556 - $53,760	2,800 Added 3.62%	80,200 $1.4 Million
Q2 2019 Aug 02, 2019	BUY	$15.01 - $18.89 $36,024 - $45,336	2,400 Added 3.2%	77,400 $1.46 Million
Q1 2019 May 10, 2019	BUY	$16.23 - $20.29 $51,936 - $64,928	3,200 Added 4.46%	75,000 $1.31 Million
Q4 2018 Feb 13, 2019	BUY	$10.77 - $18.44 $773,286 - $1.32 Million	71,800 New	71,800 $1.25 Million

Others Institutions Holding VCEL

# of Institutions

291

Shares Held

50.7M

Call Options Held

98.2K

Put Options Held

135K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.45B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Vericel Corp Transaction History